Rob Fried retweeted
NAD+ support isn’t one-size-fits-all. Unlike traditional NAD+ IVs that take hours, Niagen Plus delivers nicotinamide riboside (NR), a patented precursor the body converts into NAD+. No long infusions. A more convenient way to support NAD+ and cellular health.
Rob Fried retweeted
Niagen team gave 135 IV infusions in 48 hours at the sold-out All-In Liquidity Summit in Yountville. The event brought together leaders in business and technology, with strong interest in recovery, resilience, and proactive approaches to cellular health.
Rob Fried retweeted
Replying to @latterddssaint @CharlesMBrenner
Ask Charles he’s the expert. I know the pathways and have read the papers but he’s the expert on this.
Rob Fried retweeted
suggestions of positive activity for Niagen NR in long COVID in improving sleep quality & executive function, & reducing fatigue & depression
sciencedirect.com/science/ar…
#RCT
Rob Fried retweeted
We appreciate you highlighting our team's work and sharing this release:
.@ChromaDex announces promising findings from 2 independent clinical study abstracts originally presented at #ARVO2023. Results suggest #glaucoma patients have lower cellular NAD+ levels & replenishing levels with a precursor, like NR, may be a strategy. bit.ly/44MQyF0
Rob Fried retweeted
New game today, looks pretty interesting! THE TEMPLE OF @cybergameway @eksatech @mvgcharity @asus #hmods #supportsmallstreams #thetempleof twitch.tv/h_mods
Rob Fried retweeted
animals have homeostatic functions that allow them to repair themselves
their capacity to do so declines after they reach reproductive prime
if you want to quantify aging, quantify repair capacity
if you want to test aging interventions, test maintenance of repair capacity
Rob Fried retweeted
super interesting paper showing that NR has activity in extending lifespan of mice in DNA repair-deficient progeroid models frontiersin.org/articles/10.…
Rob Fried retweeted
ChromaDex’s Global Director of R&D Yasmeen Nkrumah-Elie sat down with @Forbes' Melissa Houston to discuss how the ChromaDex External Research Program (CERP™) has furthered NAD+ research while saving millions in R&D costs for the company. forbes.com/sites/melissahous…
Rob Fried retweeted
New preclinical study from NIH finds nicotinamide riboside (NR) helps improve #telomere dysfunction in human #cells, mice.
investors.chromadex.com/news…
Rob Fried retweeted
The results of our Phase 2 clinical trial where we used metabolic cofactor supplementation in treatment of #COVID19 patients is published @medrxivpreprint. Many thanks to @sysmedicine @HasanTurkez @ozlemaltay12
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19 medrxiv.org/cgi/content/shor… #medRxiv
Rob Fried retweeted
A new study suggests that #NAD+ repletion may have the capacity to reprogram age-related decline in circadian rhythms. Read more on @sciencedirect: sciencedirect.com/science/ar…
Rob Fried retweeted
We’re continuing our #global retail partnership with @ASWatsonGroup into Europe. Today, @truniagen is now available online and in over 200 @Superdrug stores across the U.K. More details are available here: bit.ly/35d0M3S
Rob Fried retweeted
We are proud to announce the launch of @TruNiagen Beauty, available only at Watsons Hong Kong stores and online. With this launch, we continue to broaden our #global retail partnership with A.S. Watson Group. More details are available here:
investors.chromadex.com/news…
Rob Fried retweeted
Replying to @HeerCollin
@HeerCollin @FehrLab @MichaelNADbio & I just published biorxiv.org/content/10.1101/…. This is our 1st of several works on #SARSCoV2. We show that the virus upsets the NAD system in powerful & potentially actionable ways /1
Rob Fried retweeted
“If you want to be in the business of nicotinamide riboside, there is only one provider of patented, consistently safe and regulatory approved product—and that is ChromaDex,” – ChromaDex CEO Rob Fried.
bit.ly/cdx-update
Rob Fried retweeted
This achievement is a testament to our team’s investment in clinical #research and development ensuring @TruNiagen is as effective as possible for our consumers. nutritionaloutlook.com/scien…
Rob Fried retweeted
Crossroads baseball defeats Bishop Diego in 8 innings. Jeremy Fried tossed 6 1/3 strong innings also delivered the game winning hit in the bottom of 8th. Record improves to 4-1 #GoRoads @latsondheimer @XrdsSchool
Rob Fried retweeted
There is so much disinformation going around about NMN, it's time for a tweetorial /1
Rob Fried retweeted
“We are pleased to be extending our global footprint into Europe,” says ChromaDex CEO Rob Fried. “We are committed to offering @truniagen to health-conscious people worldwide.”
finance.yahoo.com/news/europ…


















